Imugene Future Growth
Future criteria checks 3/6
Imugene is forecast to grow earnings and revenue by 58.1% and 57.3% per annum respectively. EPS is expected to grow by 58.6% per annum. Return on equity is forecast to be -66% in 3 years.
Key information
58.1%
Earnings growth rate
58.6%
EPS growth rate
Biotechs earnings growth | 14.6% |
Revenue growth rate | 57.3% |
Future return on equity | -66.0% |
Analyst coverage | Low |
Last updated | 07 Aug 2024 |
Recent future growth updates
Recent updates
Is Imugene (ASX:IMU) In A Good Position To Invest In Growth?
Aug 29We're Not Very Worried About Imugene's (ASX:IMU) Cash Burn Rate
Apr 12Here's Why We're Not Too Worried About Imugene's (ASX:IMU) Cash Burn Situation
Sep 19We're Not Very Worried About Imugene's (ASX:IMU) Cash Burn Rate
May 30Imugene (ASX:IMU) Is In A Good Position To Deliver On Growth Plans
Jan 30Here's Why Shareholders May Consider Paying Imugene Limited's (ASX:IMU) CEO A Little More
Nov 11Imugene (ASX:IMU) Is In A Good Position To Deliver On Growth Plans
Aug 22Here's Why We're Not Too Worried About Imugene's (ASX:IMU) Cash Burn Situation
Feb 28A Look At Imugene's (ASX:IMU) CEO Remuneration
Feb 17Announcing: Imugene (ASX:IMU) Stock Soared An Exciting 733% In The Last Five Years
Dec 24Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2027 | 317 | 151 | N/A | N/A | 1 |
6/30/2026 | 44 | -67 | -34 | -34 | 2 |
6/30/2025 | N/A | -98 | -54 | -54 | 2 |
6/30/2024 | -7 | -150 | -111 | -102 | N/A |
3/31/2024 | 4 | -119 | -92 | -81 | N/A |
12/31/2023 | 15 | -89 | -73 | -61 | N/A |
9/30/2023 | 13 | -64 | -52 | -46 | N/A |
6/30/2023 | 12 | -38 | -31 | -31 | N/A |
3/31/2023 | 12 | -39 | -37 | -37 | N/A |
12/31/2022 | 12 | -40 | -42 | -42 | N/A |
9/30/2022 | 13 | -39 | -36 | -36 | N/A |
6/30/2022 | 13 | -38 | -31 | -31 | N/A |
3/31/2022 | 11 | -33 | -27 | -25 | N/A |
12/31/2021 | 8 | -27 | -24 | -20 | N/A |
9/30/2021 | 8 | -23 | -21 | -16 | N/A |
6/30/2021 | 7 | -18 | -19 | -13 | N/A |
3/31/2021 | 7 | -15 | -16 | -12 | N/A |
12/31/2020 | 6 | -12 | -12 | -11 | N/A |
9/30/2020 | 5 | -11 | -12 | -11 | N/A |
6/30/2020 | 4 | -11 | -12 | -10 | N/A |
3/31/2020 | 5 | -10 | -11 | -10 | N/A |
12/31/2019 | 5 | -9 | -10 | -9 | N/A |
9/30/2019 | 5 | -8 | -9 | -8 | N/A |
6/30/2019 | 4 | -8 | -8 | -8 | N/A |
3/31/2019 | 3 | -7 | -7 | -7 | N/A |
12/31/2018 | 3 | -6 | -7 | -6 | N/A |
9/30/2018 | 2 | -5 | -6 | -5 | N/A |
6/30/2018 | 2 | -4 | -5 | -5 | N/A |
3/31/2018 | 1 | -3 | N/A | -4 | N/A |
12/31/2017 | 1 | -3 | N/A | -3 | N/A |
9/30/2017 | 1 | -3 | N/A | -3 | N/A |
6/30/2017 | 1 | -3 | N/A | -3 | N/A |
3/31/2017 | 1 | -3 | N/A | -3 | N/A |
12/31/2016 | 2 | -3 | N/A | -3 | N/A |
9/30/2016 | 2 | -3 | N/A | -3 | N/A |
6/30/2016 | 2 | -3 | N/A | -3 | N/A |
3/31/2016 | 1 | -3 | N/A | -2 | N/A |
12/31/2015 | 1 | -2 | N/A | -2 | N/A |
9/30/2015 | 1 | -2 | N/A | -2 | N/A |
6/30/2015 | 1 | -2 | N/A | -2 | N/A |
3/31/2015 | 1 | -2 | N/A | -2 | N/A |
12/31/2014 | 1 | -2 | N/A | -2 | N/A |
9/30/2014 | 1 | -2 | N/A | -1 | N/A |
6/30/2014 | 1 | -2 | N/A | -1 | N/A |
3/31/2014 | 0 | -2 | N/A | -1 | N/A |
12/31/2013 | 0 | -2 | N/A | -1 | N/A |
9/30/2013 | 0 | -2 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IMU is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.4%).
Earnings vs Market: IMU is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: IMU is expected to become profitable in the next 3 years.
Revenue vs Market: IMU is forecast to have no revenue next year.
High Growth Revenue: IMU is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: IMU is forecast to be unprofitable in 3 years.